BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

976 related articles for article (PubMed ID: 36127654)

  • 1. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
    Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J
    BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma.
    Wang S; Gao S; Shan L; Qian X; Luan J; Lv X
    PeerJ; 2023; 11():e14691. PubMed ID: 36650832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
    Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
    World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
    J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
    Xu L; Zheng Q; Liu W
    BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic signature for hepatocellular carcinoma based on 4 pyroptosis-related genes.
    Duan S; Gao J; Lou W; Zhang Y; Deng Y; Wang C; Huang H; Xu H; Guo S; Lai S; Xi F; Li Z; Deng L; Zhong Y
    BMC Med Genomics; 2022 Jul; 15(1):166. PubMed ID: 35902905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
    Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R
    Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the Pyroptosis-Related Prognosis Gene Signature and Immune Infiltration in Hepatocellular Carcinoma.
    Yu H; Bai X; Zheng W
    Dis Markers; 2022; 2022():9124216. PubMed ID: 35535333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes].
    Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP
    Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
    Wang Y; Song F; Zhang X; Yang C
    Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic values of pyroptosis-related genes for the hepatocellular carcinoma.
    Xing M; Li J
    BMC Bioinformatics; 2022 May; 23(1):177. PubMed ID: 35562678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel pyroptosis-regulated gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma.
    Zhang B; Wang Z
    Front Mol Biosci; 2022; 9():890215. PubMed ID: 36262473
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
    Dai K; Liu C; Guan G; Cai J; Wu L
    BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma.
    Fu XW; Song CQ
    Front Cell Dev Biol; 2021; 9():748039. PubMed ID: 34820376
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel association of pyroptosis-related gene signature with the prognosis of hepatocellular carcinoma.
    Li Y; Li Y; Zhang X; Duan X; Feng H; Yu Z; Gao Y
    Front Oncol; 2022; 12():986827. PubMed ID: 36267972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening prognostic markers for hepatocellular carcinoma based on pyroptosis-related lncRNA pairs.
    Wu T; Li N; Luo F; Chen Z; Ma L; Hu T; Hong G; Li H
    BMC Bioinformatics; 2023 Apr; 24(1):176. PubMed ID: 37120506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
    Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X
    Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma.
    Zhou Y; Li X; Long G; Tao Y; Zhou L; Tang J
    Front Immunol; 2022; 13():994259. PubMed ID: 36341373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma.
    Li H; Li T; Zhang X
    Front Mol Biosci; 2022; 9():822503. PubMed ID: 35309514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel defined risk signature based on pyroptosis-related genes can predict the prognosis of prostate cancer.
    Hu D; Cao Q; Tong M; Ji C; Li Z; Huang W; Jin Y; Tong G; Wang Y; Li P; Zhang H
    BMC Med Genomics; 2022 Feb; 15(1):24. PubMed ID: 35135561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.